AQUINOX PHARMACEUTICALS INC's ticker is AQXP and the CUSIP is 03842B101. A total of 47 filers reported holding AQUINOX PHARMACEUTICALS INC in Q3 2016. The put-call ratio across all filers is 0.27 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $7,000 | +600.0% | 2,850 | +658.0% | 0.00% | – |
| Q4 2018 | $1,000 | 0.0% | 376 | 0.0% | 0.00% | – |
| Q3 2018 | $1,000 | -88.9% | 376 | -89.6% | 0.00% | – |
| Q2 2018 | $9,000 | -99.0% | 3,607 | -94.2% | 0.00% | – |
| Q1 2018 | $876,000 | +968.3% | 62,202 | +788.7% | 0.00% | – |
| Q4 2017 | $82,000 | +203.7% | 6,999 | +262.6% | 0.00% | – |
| Q3 2017 | $27,000 | +17.4% | 1,930 | +16.8% | 0.00% | – |
| Q2 2017 | $23,000 | +187.5% | 1,653 | +230.6% | 0.00% | – |
| Q4 2016 | $8,000 | +14.3% | 500 | 0.0% | 0.00% | – |
| Q3 2016 | $7,000 | -63.2% | 500 | -83.1% | 0.00% | – |
| Q2 2016 | $19,000 | +46.2% | 2,953 | +193.2% | 0.00% | – |
| Q4 2015 | $13,000 | -31.6% | 1,007 | -27.3% | 0.00% | – |
| Q3 2015 | $19,000 | -85.7% | 1,385 | -92.8% | 0.00% | – |
| Q2 2015 | $133,000 | -13.6% | 19,158 | +2.4% | 0.00% | – |
| Q1 2015 | $154,000 | – | 18,710 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Prosight Management, LP | 400,900 | $1,062,000 | 0.78% |
| EMORY UNIVERSITY | 209,207 | $554,000 | 0.37% |
| EcoR1 Capital, LLC | 1,150,000 | $3,048,000 | 0.29% |
| Baker Brothers Advisors | 10,934,154 | $28,976,000 | 0.22% |
| DLD Asset Management, LP | 763,100 | $2,030,000 | 0.15% |
| UNIVERSITY OF NOTRE DAME DU LAC | 214,759 | $569,000 | 0.11% |
| Kalos Management, Inc. | 15,850 | $226,000 | 0.10% |
| SPHERA FUNDS MANAGEMENT LTD. | 257,613 | $683,000 | 0.09% |
| DLD Asset Management, LP | 379,900 | $1,007,000 | 0.08% |
| DLD Asset Management, LP | 379,300 | $1,009,000 | 0.08% |